000 01512 a2200421 4500
005 20250513130330.0
264 0 _c19971105
008 199711s 0 0 eng d
022 _a0046-8177
024 7 _a10.1016/s0046-8177(97)90254-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSoslow, R A
245 0 0 _aMIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
_h[electronic resource]
260 _bHuman pathology
_cOct 1997
300 _a1158-65 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntigens, CD34
_ximmunology
650 0 4 _aBiomarkers, Tumor
650 0 4 _aBlood Group Antigens
_ximmunology
650 0 4 _aCell Adhesion Molecules
_ximmunology
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDNA Nucleotidylexotransferase
_ximmunology
650 0 4 _aDiagnosis, Differential
650 0 4 _aHumans
650 0 4 _aImmunophenotyping
650 0 4 _aMiddle Aged
650 0 4 _aParaffin Embedding
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdiagnosis
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_ximmunology
700 1 _aBhargava, V
700 1 _aWarnke, R A
773 0 _tHuman pathology
_gvol. 28
_gno. 10
_gp. 1158-65
856 4 0 _uhttps://doi.org/10.1016/s0046-8177(97)90254-9
_zAvailable from publisher's website
999 _c9314504
_d9314504